Evidence map›Paper›PMID 24357811›Full record

ArticleRheumatology (Oxford, England)2014

Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound.

Elena Schiopu, Karen M Au, Maureen A McMahon, Mariana J Kaplan, Anagha Divekar, Ram R Singh, Daniel E Furst, Philip J Clements, Nagesh Ragvendra, Wenpu Zhao and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Elena SchiopuDivision of Rheumatology/Department of Internal Medicine, University of Michigan Scleroderma Program, Suite 7C27, 300 North Ingalls Street, SPC 5422, Ann Arbor, MI 48109, USA. khannad@med.umich.edu.
Karen M Au
Maureen A McMahon
Mariana J Kaplan
Anagha Divekar
Ram R Singh
Daniel E Furst
Philip J Clements
Nagesh Ragvendra
Wenpu Zhao
Paul Maranian
Dinesh Khanna
University of California, Los Angeles · USScleroderma Foundation · US

Funding

Systemic AutoimmunityZIAAR041199 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI KAPLAN, MARIANA · 2014 to 2025
$32.5M
Outcomes Research in Rheumatic DiseasesK24AR063120 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KHANNA, DINESH · 2012 to 2022
$1.6M
Health Values and Minimally Important Differences in Systemic SclerosisK23AR053858 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KHANNA, DINESH · 2007 to 2011
$617k
NIAMS NIH HHS K23 AR053858NIAMS NIH HHS K24 AR063120
6 · The paper itself

Abstract

objectivesSSc is associated with an increased prevalence of atherosclerosis (ATS). This study assessed the prevalence of subclinical ATS as measured by carotid US and explored serum proteins to identify potential biomarkers of SSc-ATS.

methodsForty-six SSc female patients and 46 age- and ethnicity-matched controls underwent carotid US to assess the presence of plaque and carotid intima media thickness (CIMT). Abstracted data included demographics, ATS risk factors and serum measurements [cholesterol, proinflammatory high-density lipoprotein (piHDL), CRP, lipoproteins]. Serum cytokines/proteins analyses included circulating type I IFN activity by quantifying IFN-inducible genes, soluble junctional adhesion molecule A (sJAM-A) and 100 serum proteins by using a microplate-based multiplex platform. Proteins significant at P < 0.05 on bivariate analyses for the presence of plaque were used to develop a composite measure.

resultsPatients with SSc had more plaque (45.6% vs 19.5%, P = 0.01) but similar CIMT compared with controls. Multiplex analysis detected significant associations between serum proteins of inflammation, vasculopathy and fibrosis with ATS in SSc, including IL-2, IL-6, CRP, keratinocyte growth factor, intercellular adhesion molecule 1, endoglin, plasminogen activator inhibitor 1 and insulin-like growth factor binding protein 3 associated with carotid plaque. Myeloid progenitor inhibitory factor 1, serum amyloid A, thrombomodulin, N-terminal pro-brain natriuretic peptide (BNP), and Clara cell secretory protein 16 kD correlated with CIMT. The median composite score for the plaque group was 6 and for the no plaque group it was 2 (P < 0.0001).

conclusionPatients with SSc have a higher prevalence of carotid plaque than matched controls, and patients with SSc-plaque vs patients without plaque have elevated serum proteins implicated in both vasculopathy and fibrosis. Further studies are needed to evaluate the role of these proteins in SSc compared with healthy controls.

Indexed as

AdultAntigens, CDAsymptomatic DiseasesBiomarkersCarotid ArteriesCarotid Artery DiseasesCarotid Intima-Media ThicknessCase-Control StudiesChemokines, CCC-Reactive ProteinCross-Sectional StudiesEndoglinFemaleFibroblast Growth Factor 7HumansInsulin-Like Growth Factor Binding Protein 3Antigens, CDBiomarkersCCL23 protein, humanChemokines, CCC-Reactive ProteinEndoglinENG protein, humanFGF7 protein, humanFibroblast Growth Factor 7ICAM1 protein, humanIGFBP3 protein, humanIL2 protein, humanIL6 protein, humanInsulin-Like Growth Factor Binding Protein 3Intercellular Adhesion Molecule-1Interleukin-2Interleukin-6Natriuretic Peptide, BrainPeptide FragmentsPlasminogen Activator Inhibitor 1pro-brain natriuretic peptide (1-76)Receptors, Cell SurfaceSerum Amyloid A ProteinTHBD protein, humanThrombomodulinUteroglobinatherosclerosiscarotid intima media thicknessendothelial dysfunctionserum proteinssystemic sclerosistype I interferon

Identifiers

PMID24357811
PMCPMC4042927
OpenAlexW2103785471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.